Details for 2022754412
Up to date per 05.04.2026
Actions
Details for 2022754412
Granted/Registered
European Patent
05.06.2024 A
25.03.2026 B1
26.07.2021
EP
21187721
A61K 31/40 20060101AFI20230203BHEP
Owner
NewAmsterdam Pharma B.V.Gooimeer 2-35 1411 DC NaardenNL
Representative
No representatives present
Inventor
KASTELEIN, Johannes Jacob Pieter 1411 DC NaardenNL
DITMARSCH, Marc 1411 DC NaardenNL
DAVIDSON, Michael Harvey 1411 DC NaardenNL
Information about Fees